Enveric Biosciences
Cambridge, Massachusetts, United States · Biotechnology, Healthcare, Health Care
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the wor
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 12
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (ENVB)
- Website
- enveric.com
- Company page
Recent activity at Enveric Biosciences
- : Enveric Biosciences
- : Enveric Biosciences
- : Enveric Biosciences
- : Enveric Biosciences Expands Patent Protection for EVM301 Portfolio with New Issuances to Enhance Value-Capture Opportunities.
- : Enveric Biosciences and Aries Science & Technology Announce Licensing Agreement for Treatment of Radiation Dermatitis and Other Conditions
- : Enveric Biosciences and Aries Science & Technology Announce Licensing Agreement for Clinical Development of Radiation Dermatitis Topical Product
- : Enveric Biosciences
- : Enveric Biosciences
- : Enveric Biosciences Announces Closing Of Magicmed Industries Acquisition
- : Enveric Biosciences, Inc.
Enveric Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| May 2026 | Venture | $5.0M |
| Feb 2026 | Venture | $1.5M |
| Dec 2025 | Venture | $107K |
| Aug 2022 | Venture | $8.6M |
| Feb 2021 | Venture | Undisclosed |
Leadership
- Sheetal Raithatha, Director of Preclinical Development
- David Johnson, Executive Officer, Director
- Avani Kanubaddi, Executive Officer, Director
- George Kegler, Director
- Sol Mayer, Director
- Marcus Schabacker, Director
- Jillian Hagel, Vice President of Innovation
- Kevin Coveney, Chief Financial Officer
Verified email and direct lines for Enveric Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Enveric Biosciences in the news
- Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003 - Business Wire (Jun 02, 2026)
- Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model - Business Wire (May 05, 2026)
- Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire (Apr 17, 2026)
- Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - Business Wire (Aug 14, 2026)
- Enveric Biosciences Announces Participation in 2026 BIO International Convention - Business Wire (Jun 16, 2026)
- Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates - Business Wire (Mar 31, 2026)
- Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Business Wire (Jun 09, 2026)
- Enveric Biosciences Reports Differentiated Brain Activity Profile for EB-003 in Preclinical qEEG Study - Business Wire (Nov 04, 2026)
Companies similar to Enveric Biosciences
- Sydnexis · Biotechnology, Healthcare, Health Care, Science And Engineering
- Bond Biosciences · Biotechnology, Healthcare, Health Care, Science And Engineering
- Bigfoot Biomedical, Inc. · Biotechnology, Healthcare, Health Care, Science And Engineering
- Athos Therapeutics, Inc. · Biotechnology, Healthcare, Health Care, Science And Engineering
- SEELOS THERAPEUTICS, INC. · Biotechnology, Healthcare, Health Care, Science And Engineering
About Enveric Biosciences: questions and answers
What does Enveric Biosciences do?
Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the wor
Where is Enveric Biosciences headquartered?
Enveric Biosciences is headquartered in Cambridge, Massachusetts, United States.
How many employees does Enveric Biosciences have?
Enveric Biosciences has about 12 employees.
Has Enveric Biosciences raised funding?
Yes. Fundz has recorded 5 funding events for Enveric Biosciences. The most recent, $5.0M, was in May 2026.
Who leads Enveric Biosciences?
Jillian Hagel is a Vice President of Innovation at Enveric Biosciences.
What is the latest news on Enveric Biosciences?
On May 04, 2026, Enveric Biosciences
Is Enveric Biosciences a public company?
Yes. Enveric Biosciences is publicly traded under the ticker ENVB.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy